Home > Online Clinic News > Avanafil Approved in the EU

Latest News

by Robert MacKay, Tuesday, April 30, 2013 | Categories: Erectile Dysfunction

Another alternative to Viagra is expected to be available soon in the European Market. The pill will be called Spedra and Avanafil is the active ingredient. The medication, which is awaiting marketing authorisation from the European Commission, has been given a green light from the Committee for Medicinal Products for Human Use (CHMP).

A few people are wondering whether this alternative medication for Erectile Dysfunction will be a valuable option in the European market, since there are already two alternatives to Viagra –namely, Levitra and Cialis. As with any medication, Avanafil can cause side effects which include: headaches, indigestion and back pain. However, Avanafil has got a distinctive characteristic that is appealing to some erectile dysfunction patients: it is able to help achieve an erection in as little as 15 minutes.

The Food and Drug Administration (FDA) has just approved the medication under the name of Stendra but it is not yet being manufactured.

We expect that the manufacturer will want to launch this product as soon as possible so we may be in a position to prescribe this medication within the next few months.

We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close